Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.

H, Kreis; JM, Cisterne; W, Land; L, Wramner; JP, Squifflet; D, Abramowicz; JM, Campistol; JM, Morales; JM, Grinyo; G, Mourad; FC, Berthoux; C, Brattström; Y, Lebranchu; P, Vialtel

doi:10.1097/00007890-200004150-00009

Public

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.

Shared by NobleBlocks on Apr 1, 2000 • 12:00 AM UTC

Authors:

Kreis H

Cisterne JM

Land W

Abstract

Introduction A previous trial in renal transplantation comparing sirolimus (rapamycin) to cyclosporine (CsA) in a triple-drug therapy regimen with azathioprine and corticosteroids found that the incidence of acute rejection was similar (approximately 40%) with a trend for better renal function with ...

Discussions